Question to the Department of Health and Social Care:

To ask the Secretary of State for Health and Social Care, what steps his Department is taking to assess the effectiveness of covid-19 vaccines for those with compromised immune systems.

Public Health England is working with a range of partners to monitor the effectiveness of COVID-19 vaccinations in clinical risk groups, including those with immunosuppression.

Public Health England recently published data on COVID-19 vaccine effectiveness for clinical risk groups. It showed that for those who are immunosuppressed, vaccine effectiveness after a second COVID-19 vaccine dose is 74%, with similar protection to those who are not in a risk group. This rises from 4% after a first dose of COVID-19 vaccine.